Joanna Yi

12PUBLICATIONS
92CO-AUTHORS
Molecular targetsNeonatologyGene and molecular therapyHaematological tumoursPaediatrics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 25, 2026
CAMKV kinase drives neuroblastoma growth and acts as a novel therapeutic target.

|Jul 30, 2026
Recurrent Hypoglycemia Following Asparaginase Therapy for Lymphoid Malignancies in Childhood: The Texas Children's Hospital Experience.

|Sep 19, 2025
FLAG-IDA plus venetoclax for children, adolescents, and young adults with newly diagnosed AML.

Reeja Raj, Samanta Catueno, Amber Gibson

|Aug 19, 2025
An analysis of diagnostic metabolomic profiles associated with hepatotoxicity during childhood ALL induction therapy.

Emily J Mason, Anna M Crain, Michael E Scheurer

|May 27, 2024
EZH2-driven immune evasion at disease presentation defines a targetable high-risk subset of acute leukemia exemplified by t(16;21) FUS::ERG AML.

Nathaniel J Buteyn, Samantha J LaMantia, Connor G Burke

|Jan 18, 2024
KMT2A oncoproteins induce epigenetic resistance to targeted therapies.

Derek H Janssens, Melodie Duran, Dominik J Otto

Pageof 2

Frequent Collaborators

2 joint publications

David McCall

2 joint publications

Courtney D DiNardo

2 joint publications

Miriam Garcia

2 joint publications

Amber Gibson